Spectral AI (MDAI) Net Income towards Common Stockholders Growth (1y) (2022 - 2026)
Spectral AI (MDAI) Net Income towards Common Stockholders Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.28 Bn | 193.68 Bn | 7.27 Bn | -47.84% |
| 2 | Stryker | 129.49 Bn | 126.02 Bn | 4.50 Bn | 44.34% |
| 3 | Medtronic | 119.55 Bn | 110.33 Bn | 6.41 Bn | 18.55% |
| 4 | Boston Scientific | 73.67 Bn | 73.13 Bn | 3.85 Bn | 13.80% |
| 5 | Edwards Lifesciences | 52.28 Bn | 48.03 Bn | 1.35 Bn | -27.18% |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn | 38.54% |
| 7 | GE HealthCare Technologies | 34.13 Bn | 32.02 Bn | 2.18 Bn | 14.80% |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn | 73.85% |
| 9 | Steris | 23.17 Bn | 22.69 Bn | 684.20 Mn | 12.92% |
| 10 | Spectral AI | 50.53 Mn | 36.53 Mn | 1.11 Mn | 47.59% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 47.59% |
| Mar 31, 2026 | -227.46% |
| Dec 31, 2025 | 125.01% |
| Sep 30, 2025 | -136.17% |
| Jun 30, 2025 | -178.21% |
| Mar 31, 2025 | 183.53% |
| Dec 31, 2024 | -113.90% |
| Sep 30, 2024 | 85.85% |
| Jun 30, 2024 | 6.71% |
| Mar 31, 2024 | 11.19% |
| Dec 31, 2023 | -103.91% |
| Sep 30, 2023 | -2,697.11% |
| Jun 30, 2023 | -310.42% |
| Mar 31, 2023 | -124.77% |
| Dec 31, 2022 | 80.41% |
| Sep 30, 2022 | -106.73% |
| Jun 30, 2022 | 150.26% |
| Mar 31, 2022 | 120.76% |